A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the overall safety and efficacy of TRV027 when administered in addition to
standard of care (SOC) on mortality, morbidity, dyspnea, and length of stay in patients
hospitalized with Acute Decompensated Heart Failure (ADHF).